PREVALENCE OF THROMBOCYTOPENIA AND ITS IMPACT ON MORTALITY AMONG NEONATES WITH NEONATAL SEPSIS

Main Article Content

Atta ul Rehman Saadi
Rabia Bashir
Muhammad Shoaib
Sattra Sehar
Muhammad Zain UL Aabidin
Shehryar Haider

Keywords

Neonatal sepsis, thrombocytopenia, neonatal mortality, neonatal intensive care, Escherichia coli, Staphylococcus aureus, Group B Streptococcus, Klebsiella species

Abstract

Background: Neonatal sepsis is a leading cause of morbidity and mortality in newborns, often complicated by thrombocytopenia. Understanding the prevalence of thrombocytopenia and its impact on neonatal outcomes is crucial for improving management and survival rates.


Objective: This study aims to determine the prevalence of thrombocytopenia among neonates with sepsis and assess its impact on in-hospital mortality.


Methods: We conducted a retrospective cohort study of 150 neonates diagnosed with sepsis in the neonatal intensive care unit (NICU) at Shaikh Zayed Hospital, Lahore. Data on demographic characteristics, clinical features, isolated pathogens, and outcomes were collected from electronic medical records. Thrombocytopenia was defined as a platelet count <150,000/µL. Logistic regression was used to analyze the association between thrombocytopenia and mortality, adjusting for potential confounders.


Results: The mean gestational age of the neonates was 32.5 ± 3.2 weeks, and the mean birth weight was 1.8 ± 0.5 kg. Thrombocytopenia was present in 80% of the neonates. The most common pathogens isolated were Escherichia coli (30%), Staphylococcus aureus (25%), and Streptococcus (20%), and Klebsiella species (15%). In-hospital mortality was significantly higher in neonates with thrombocytopenia (20.8%) compared to those without (3.3%). Logistic regression analysis showed that thrombocytopenia was significantly associated with increased in-hospital mortality (adjusted odds ratio: 4.2; 95% CI: 1.5-12.0; p=0.007).


Conclusion: Thrombocytopenia is highly prevalent among neonates with sepsis and is associated with a significantly increased risk of in-hospital mortality. These findings highlight the importance of early detection and management of thrombocytopenia in improving outcomes for neonates with sepsis.

Abstract 34 | pdf Downloads 16

References

1. Parmar D, Desai H, Goswami H. Study of thrombocytopenia and platelet indices in neonatal sepsis. Intern J of Clinical and Dignostic Pathology. 2020;3(4):39-42.
2. Addil F, Rehman A, Najeeb S, Imtiaz H, Khan S. Neonatal sepsis: the frequency of thrombocytopenia. Sys Rev Pharm. 2021 Jun 21;12(11):3460-2.
3. Alazem A, Abobakr E, Abdel Ghany E, Zaky SA, Abd Elhady M. Thrombocytopenia is more Frequent in Gram negative Neonatal Septicemia. Pediatric Sciences Journal. 2022 Jul 1;2(2):147-56.
4. Hussain G, Ahmad F, Akhtar S, Khan S. To Determine the Frequency of Thrombocytopenia in Neonatal Sepsis. Pakistan Journal of Medical & Health Sciences. 2022;16(11):417-.
5. Ahmed AA, Elderdery AY, Atif M, Mohamed BA, Imran M. Impact of bacterial sepsis on thrombocytes and mortality rate in Sudanese neonates. Rawal Medical Journal. 2020 Jul;45(3):602-.
6. Chavan AN, Tambe SH, Karemore M, Inamdar IA, Dhurve P. Study of Clinical and Outcome Profile of Neonatal Sepsis with Thrombocytopenia Patients Admitted at Tertiary health care Centre Nanded. Perspectives. 2022 Sep;10(3):94.
7. Adane T, Worku M, Tigabu A, Aynalem M. Hematological abnormalities in culture positive neonatal sepsis. Pediatric Health, Medicine and Therapeutics. 2022 Jun 7:217-25.
8. Gialamprinou D, Mitsiakos G, Katsaras GN, Kontovazainitis CG, Karagianni P, Roilides E, Kenet G. Neonatal sepsis and hemostasis. Diagnostics. 2022 Jan 20;12(2):261.
9. Arabdin M, Khan A, Zia S, Khan S, Khan GS, Shahid M. Frequency and severity of thrombocytopenia in neonatal sepsis. Cureus. 2022 Feb;14(2).
10. Arif H, Ikram N, Riaz S, Arif AN, Ikram N, Riaz S, Nafisa A. Risk factors and outcome of neonatal thrombocytopenia. Journal of Rawalpindi Medical College. 2020 Sep 30;24(3).
11. Addil F, Rehman A, Najeeb S, Imtiaz H, Khan S. Neonatal sepsis: the frequency of thrombocytopenia. Sys Rev Pharm. 2021 Jun 21;12(11):3460-2.
12. Parmar D, Desai H, Goswami H. Study of thrombocytopenia and platelet indices in neonatal sepsis. Intern J of Clinical and Dignostic Pathology. 2020;3(4):39-42.
13. Wodaje M, Tadele N, Lijaemiro H, Demtse A, Birhanu D, Tadele H, Belege F. Prevalence of Thrombocytopenia and Its Associated Factors Among Neonates Admitted in Neonatal Intensive Care Unit of Addis Ababa Public Hospitals, Ethiopia 2020/21 (Cross Sectional Study).
14. Roberts I, Murray NA. Thrombocytopenia in neonates with sepsis. Curr Opin Infect Dis. 2012;25(3):297-305.
15. Guida JD, Kunig AM, Leef KH, McKenzie SE, Paul DA. Platelet count and sepsis in very low birth weight neonates: Is there an organism-specific response? Pediatrics. 2013;111(6):1411-1415.
16. Manzoni P, Rizzollo S, Galletto P, et al. Thrombocytopenia and risk of significant clinical bleeding in very low birth weight infants: A retrospective cohort study. J Pediatr. 2009;154(1):66-70.
17. Carroll PD, Christensen RD. New and underutilized therapies for neonatal sepsis. Clin Perinatol. 2014;40(1):103-115.
18. Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817-826.
19. Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006-1015.
20. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B Streptococcal disease in the era of maternal screening. Pediatrics. 2017;140(4)

Most read articles by the same author(s)

1 2 > >>